Ervaringen met MRI-geleide brachytherapie bij prostaatkankerrecidief

Translated title of the contribution: Experiences with MRI-guided brachytherapy for radiorecurrent prostate cancer

Marnix J.A. Rasing, Max Peters, M. A. Moerland, Juus L. Noteboom, Jan J. Lagendijk, Jochem R.N. van der Voort van Zyp

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

MR-guided brachytherapy offers a focal salvage treatment for the local recurrence in case of isolated locally recurrent prostate cancer in the prostate and/or seminal vesicles after primary radiotherapy. By focusing on only the local recurrence instead of the whole prostate, chances of additional toxicity of the bladder, urethra and rectum can be minimized. In almost all patients, the treatment leads to a good initial treatment response that persists in about half of patients, while others will develop progressive disease later on. For selecting suitable patients, factors such as preexistent urinary- and bowel complaints, localization and size of the recurrence, PSA doubling time and time between primary radiotherapy and development of the recurrence are relevant. MR-guided brachytherapy can provide a suitable salvage strategy, with the aims of deferring androgen deprivation therapy and a chance of cure.

Translated title of the contributionExperiences with MRI-guided brachytherapy for radiorecurrent prostate cancer
Original languageDutch
Article numberd6966
JournalNederlands Tijdschrift voor Geneeskunde
Volume166
Publication statusPublished - 5 Oct 2022

Keywords

  • Male
  • Humans
  • Brachytherapy
  • Prostatic Neoplasms/radiotherapy
  • Prostate-Specific Antigen
  • Androgen Antagonists
  • Androgens
  • Neoplasm Recurrence, Local/radiotherapy
  • Magnetic Resonance Imaging

Fingerprint

Dive into the research topics of 'Experiences with MRI-guided brachytherapy for radiorecurrent prostate cancer'. Together they form a unique fingerprint.

Cite this